SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

The conversation is dominated by frustration and political polarization following the U.S. Senate's failure to advance the Crypto Clarity Act. While some traders view the legislative impasse as a temporary setback and an opportunity to accumulate at lower prices, others express cynicism, predicting further volatility and questioning the long-term prospects of crypto regulation in the current political environment.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending as investors digest a series of insider purchases by the CEO and a company director, which the community largely views as a bullish signal that the stock price has bottomed. While some traders express skepticism or label the activity as optics, many others are using the purchases as justification to add to their long positions despite lingering concerns regarding the company's core brand performance.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as traders speculate on positive guidance updates following recent conference appearances and anticipate upcoming Phase 2 NSCLC data. Community sentiment remains focused on institutional accumulation and the company's solid tumor platform as a long-term value driver.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is facing significant selling pressure and reaching new lows, with the community largely attributing the decline to a challenging macroeconomic environment characterized by high interest rates, rising oil prices, and broader housing market headwinds. While many investors express frustration over the sustained downtrend and ongoing share dilution, others maintain a long-term bullish thesis, viewing the current price as a value opportunity driven by the company's platform-building strategy and significant institutional involvement.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as traders discuss the company's recent delivery of its SXM-11 satellite to SiriusXM following successful in-orbit testing, while sentiment remains divided between bulls focused on long-term lunar economy contracts and bears concerned about technical weakness, dilution risks, and macro-driven sell-offs.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is trending due to heightened buyout speculation, bolstered by its strong CARVYKTI commercial performance and potential for a significant valuation re-rate upon upcoming in vivo CAR-T data readouts. Investors are closely monitoring the leadership transition and the company's strategic positioning within the competitive multiple myeloma market as a potential acquisition target for larger pharmaceutical firms.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending following the final Phase 3 ORIGIN 3 trial results for Trutakna, which demonstrated a 76% reduction in kidney disease progression risk and stabilized kidney function in patients with IgA nephropathy. The community is focused on the planned Q4 2026 supplemental FDA filing for full approval, with many traders discussing potential short squeezes and a favorable competitive positioning relative to other IgAN treatments.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer is experiencing significant selling pressure following the expiration of its post-IPO insider lock-up period, which has made a large portion of the share supply available for trading. While some traders are capitalizing on the dip, viewing the stock as oversold or noting the recent acquisition of Ratel Robotics as a long-term catalyst, others are concerned about potential dilution and the company's limited revenue history.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Investors are closely watching the stock's clinical progress, specifically positive trial results for Alpha DaRT in combination with immunotherapy and the company's efforts to expand trials in the U.S. While some traders point to potential price manipulation or broader market volatility, many remain bullish, expecting significant valuation growth as new clinical data and regulatory milestones are reached.

Wingstop, Inc. is a franchisor and chicken wings-focused restaurant. The firm is engaged in the flavor business offering cooked-to-order, hand-sauced, and tossed classic and boneless wings, tenders and chicken sandwiches in flavors, with signature sides, such as its seasoned fries and house made ranch and bleu cheese dips. The company was founded in 1994 and is headquartered in Dallas, TX.

Wingstop Inc

Wingstop shares have been heavily pressured by a broader retail and dining sector selloff, driven by macroeconomic concerns including rising consumer costs and data showing declining restaurant foot traffic. The community is split, with some traders viewing the decline as a generational buying opportunity due to the company's long-term growth profile and unit expansion, while others remain skeptical, citing valuation concerns and increased competition in the casual dining space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ULS
Current Stock Price: $92.58
Contracts to trade: $95.0 ULS Jul 17 2026 Call
Entry: $1.85
Exit: $2.47
ROI: 34%
Hold ~30 days

Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

AI Powered Insights Get daily AI-generated picks that are primed to give you an edge. Join thousands of users who are getting smarter with our insights. Join thousands of users getting insightful AI-powered content delivered daily. 100% Free * No Credit Card Required * Disclaimer: The information provided is for educational purposes only and should not be considered professional advice.

Dailypickai

DailyPickAI

StockTwits Web

UL Solutions Inc.


Current Stock Price: $92.58
Contracts to trade: $95.0 ULS Jul 17 2026 Call
Entry: $1.85
Exit: $2.47
ROI: 34%
Hold ~30 days

Shared as daily free alerts and for educational purposes only. 